Skip to content

Sotorasib

Published: July 26, 2026Updated: July 26, 2026

Sotorasib is a targeted cancer therapy that inhibits the KRAS G12C mutant protein, a driver of tumor growth in certain cancers. It is approved for use in adults with advanced non-small cell lung cancer (NSCLC) that has a KRAS G12C mutation and has progressed after at least one prior systemic therapy.

Quick summary

Sotorasib is an oral KRAS G12C inhibitor used to treat mutant KRAS-positive non-small cell lung cancer.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
L01XX73
RxNorm
2550714
Generic
Sotorasib
Class
atc-l01
Brands
Lumakras
Availability
rx
Lactation
unknown
Routes
oral
Forms
tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy. Requires confirmation of KRAS G12C mutation through FDA-approved testing before use.

Sotorasib is a KRAS G12C inhibitor that forms an irreversible, covalent bond with the unique cysteine residue of the mutant KRAS G12C protein, locking it in an inactive GDP-bound state and preventing downstream oncogenic signaling pathways that drive tumor growth.

Taken orally once daily with or without food. Common side effects include diarrhea, fatigue, nausea, and musculoskeletal pain. May cause hepatotoxicity requiring monitoring of liver function. Patients should be advised to report any signs of interstitial lung disease. Effectiveness requires KRAS G12C mutation confirmation prior to treatment initiation.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy